Abstract
Although oral probiotics can improve breast microecology and alleviate the inflammatory response, there are no data regarding cases with existing abscesses. We aimed to investigate the effect of Lactobacillus fermentum CECT5716 during needle aspiration in patients with lactational breast abscesses. Patients (aged 20-41 years) with lactational single-cavity breast abscesses (diameter 3-6 cm) from 12 hospitals were randomly assigned to the experimental (n = 51) and control groups (n = 50). Outcome measures included the abscess cure rate on treatment day-5, delactation rate, relieving pain rate, and number of needle aspirations until day-28. The experimental group's 5-day cure rate (43.1%) was significantly higher (p < 0.05). Breastfeeding continuation on day-5 did not differ significantly (experimental group: 88.2%, control group: 96.0%, p = 0.269). In the experimental and control groups, 19.6% and 14.0% of patients experienced moderate to severe pain on day-5, respectively, with no statistically significant differences (p = 0.451). Four patients in each group developed diarrhea, with adverse reaction rates of 7.84% and 8.0%, respectively. No adverse reactions were reported in the infants. L. fermentum can shorten the healing time in patients with lactational breast abscesses.
Introduction
Lactational mastitis and subsequent breast abscesses are primary medical reasons for the undesired cessation of breastfeeding. While traditional treatments involve antibiotics or surgical incision and drainage, these methods face challenges from antibiotic resistance and can lead to significant pain and scarring. Ultrasound-guided needle aspiration has become a preferred, less invasive alternative, but healing times can still be protracted.
This study explores the biological hypothesis of the "entero-mammary pathway," where bacteria travel from the mother's gut to the mammary glands. By framing mastitis as a disruption of "breast microecology" rather than just an external infection, researchers investigated whether the oral probiotic Lactobacillus fermentum CECT5716 could serve as a safe, effective adjunct to restore bacterial diversity and accelerate recovery.
Methods
The researchers conducted a prospective, multi-center, randomized, double-blind, controlled trial across 12 hospitals in China. Participants included 110 lactating women (aged 20–41) with single-cavity breast abscesses (3–6 cm in diameter) who had undergone needle aspiration. The experimental group received one sachet of L. fermentum CECT5716 daily for four weeks, while the control group received a maltodextrin placebo. Both groups received routine ultrasound-guided needle aspiration as needed. The primary metric was the "cut-off" cure rate on day 5 of treatment, defined as the complete disappearance of the abscess and local symptoms.
Results
The addition of probiotics significantly accelerated healing. The primary outcome was striking: the 5-day cure rate was 43.1% in the probiotic group compared to only 18.0% in the control group (p = 0.006). Multivariate logistic regression confirmed that the risk of not being cured by day 5 was significantly lower in the experimental group (Odds Ratio: 0.282, 95% CI: 0.112–0.713).
Secondary outcomes showed no significant interference with lactation or patient comfort. There was no statistically significant difference in breastfeeding rates on day 5 (88.2% experimental vs. 96.0% control, p = 0.269). Pain levels were also similar between groups, with 19.6% and 14.0% reporting moderate to severe pain, respectively (p = 0.451). Adverse reactions were mild (diarrhea in ~8% of both groups) and resolved spontaneously, with no adverse reactions reported in infants.
Discussion and Conclusion
These findings suggest that L. fermentum CECT5716 acts as an effective biological adjunct to mechanical drainage. While aspiration addresses the "macro" accumulation of pus, the probiotic addresses the "micro" environment by restoring microbial diversity and alleviating inflammation. Although limited by a relatively small sample size and potential technical variability across centers, the trial demonstrates that probiotics can safely shorten healing times for lactational breast abscesses without compromising breastfeeding continuity. Larger-scale studies are recommended to further clarify the relationship between specific probiotic strains and various bacterial pathogens.
Summary updated